U.S. Food & Drug Administration Chief Dr. Scott Gottlieb Resigns

U.S. Food and Drug Administration (FDA) commissioner Scott Gottlieb, MD, recently submitted his letter of resignation from his position. The move will see Dr. Gottlieb likely leaving the federal agency this April.

Dr. Gottlieb cited wanting to spend more time with his family as the primary reason for deciding to leave the agency, which he initially joined in 2017. During his time with the FDA, Dr. Gottlieb was known for going after the e-cigarettes industry, as well as his fervor in tackling the nation’s opioid epidemic.

The Food and Drug Administration (FDA) is a federal agency of the United States Department of Health and Human Services, one of the United States federal executive departments. The FDA is responsible for protecting and promoting public health through the control and supervision of food safety, dietary supplements, medications, vaccines, biopharmaceuticals, medical devices, and other products.

This was reported by Becker’s Hospital Review on March 5, 2019.

Contact Information: U.S. Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, Maryland 20993; (888) 463-6332; Website: www.fda.gov

Tagged As:

COVID-19 Risk Management Plan August 11, 2021

We are excited to return to sunny southern California for The 2021 OPEN MINDS Management Best Practices Institute at the picturesque Newport Beach Marriott Hotel & Spa, August 23-26, 2021. To help plan your in-person attendance, visit https://openminds.com/live-mbpi/ for a schedule of events happening throughout the week.

The resurgence of the COVID Delta variant has certainly created new challenges for the country and for our families. Fortunately, the available COVID vaccinations have been very successful in preventing symptomatic infections and illness. But I did want to let you know that our team at OPEN MINDS is committed to making our executive events as safe as possible and have an active risk management plan in place. I wanted to share with you the key elements of our plan:

Masking. Every participant will receive a mask as part of their registration materials. Unvaccinated people will be required to wear masks – and vaccinated attendees will be encouraged to wear masks. If the local or state governments have more restrictive standards (including mandatory masking or requiring proof of vaccination) at the time of our institutes, we will follow those standards.

Social Distancing. We are working with the event venue to hold all sessions in the largest possible rooms with seating as far apart as possible. In order to accomplish this, we ask that you select in advance the sessions you plan to attend in-person at the event venue. This will assist us with room and seating arrangements.

Outdoor Events. Where possible, we will use outdoor spaces for networking events and smaller sessions.

Hand Sanitation. Hand sanitation stations are available throughout the event venue and hand sanitizer is included in your registration materials, courtesy of our partner, Qualifacts+Credible.

Virtual Sessions. Every session will be partially or fully available in a virtual capacity:

We are livestreaming via GoToWebinar our plenary sessions – keynote addresses and plenary panels. You can participate online from your hotel room (or from your home office if you can’t attend on-site). We will be accepting questions from both the onsite and online audiences.
Each executive seminar is being offered at two separate times, one live at the event venue and the other exclusively for virtual attendees.
We are recording the audio for each session – and will post the audio along with presentation materials after each session.
A virtual exhibit hall will be available with access to all exhibitor contact information, product demos, and engagement opportunities.

We will continue to monitor any changes in the CDC recommendations for the continued safety of the public. If you have any concerns or questions, feel free to reach out to a member of our team at events@openminds.com or by phone at 877-350-6463. We look forward to seeing you at The 2021 OPEN MINDS Management Best Practices Institute.

Monica E. Oss
Chief Executive Officer
OPEN MINDS

U.S. Food & Drug Administration Chief Dr. Scott Gottlieb Resigns

Tagged As:

Site Footer

COVID-19 Risk Management Plan August 11, 2021

Tagged As: